Literature DB >> 1536332

A prospective study of the attributable risk of cancer due to cigarette smoking.

P H Chyou1, A M Nomura, G N Stemmermann.   

Abstract

BACKGROUND: The goals of this study were to measure the impact of cigarette smoking on cancer incidence and to determine the attributable risk of cancer due to smoking.
METHODS: A cigarette smoking history was obtained from 8006 Japanese-American men examined from 1965 through 1968. After 22 years, 1389 incident cases of cancer were identified. There were 212 men with lung cancer; 202 with oral, esophageal, laryngeal, pancreatic, renal, ureteral, or bladder (oral-bladder) cancer; and 975 with cancer at other sites.
RESULTS: Current smokers at time of examination had a higher incidence than nonsmokers for each of the three cancer site categories. Eighty-five percent of lung cancer cases diagnosed among current and never smokers can be attributed to cigarette smoking. The attributable risks were 46%, 16%, and 29%, respectively, for oral-bladder cancers, other cancers, and all cancers combined. In turn, the corresponding attributable risks were 60%, 26%, 13%, and 21% in comparing current smokers with past smokers.
CONCLUSIONS: Current smokers can greatly reduce their risk of cancer, especially lung cancer, if they quit smoking.

Entities:  

Mesh:

Year:  1992        PMID: 1536332      PMCID: PMC1694406          DOI: 10.2105/ajph.82.1.37

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  20 in total

1.  Cancer statistics, 1991.

Authors:  C C Boring; T S Squires; T Tong
Journal:  CA Cancer J Clin       Date:  1991 Jan-Feb       Impact factor: 508.702

2.  Tobacco and cancer.

Authors:  E T Fontham; P Correa; V W Chen; J F Craig; L W Pickle; R Falk
Journal:  J La State Med Soc       Date:  1988-04

3.  Smoking and mortality: a prospective study.

Authors:  J M Weir; J E Dunn
Journal:  Cancer       Date:  1970-01       Impact factor: 6.860

4.  Smoking and cancer of the lower urinary tract.

Authors:  P Cole; R R Monson; H Haning; G H Friedell
Journal:  N Engl J Med       Date:  1971-01-21       Impact factor: 91.245

5.  Estimating the population attributable risk for multiple risk factors using case-control data.

Authors:  P Bruzzi; S B Green; D P Byar; L A Brinton; C Schairer
Journal:  Am J Epidemiol       Date:  1985-11       Impact factor: 4.897

6.  Smoking and cancer in the United States.

Authors:  E C Hammond; H Seidman
Journal:  Prev Med       Date:  1980-03       Impact factor: 4.018

7.  Mortality in relation to smoking: 20 years' observations on male British doctors.

Authors:  R Doll; R Peto
Journal:  Br Med J       Date:  1976-12-25

8.  Coffee and cancer of the pancreas.

Authors:  B MacMahon; S Yen; D Trichopoulos; K Warren; G Nardi
Journal:  N Engl J Med       Date:  1981-03-12       Impact factor: 91.245

9.  Mortality in middle-aged smokers and nonsmokers.

Authors:  G D Friedman; L G Dales; H K Ury
Journal:  N Engl J Med       Date:  1979-02-01       Impact factor: 91.245

10.  Smoking and lung cancer with special regard to type of smoking and type of cancer. A case-control study in north Sweden.

Authors:  L A Damber; L G Larsson
Journal:  Br J Cancer       Date:  1986-05       Impact factor: 7.640

View more
  18 in total

1.  Evaluating Lung Cancer Screening Across Diverse Healthcare Systems: A Process Model from the Lung PROSPR Consortium.

Authors:  Chyke A Doubeni; Debra P Ritzwoller; Katharine A Rendle; Andrea N Burnett-Hartman; Christine Neslund-Dudas; Robert T Greenlee; Stacey Honda; Jennifer Elston Lafata; Pamela M Marcus; Mary E Cooley; Anil Vachani; Rafael Meza; Caryn Oshiro; Michael J Simoff; Mitchell D Schnall; Elisabeth F Beaber; V Paul Doria-Rose
Journal:  Cancer Prev Res (Phila)       Date:  2019-12-23

2.  Childhood sexual abuse and bulimic behavior in a nationally representative sample.

Authors:  S A Wonderlich; R W Wilsnack; S C Wilsnack; T R Harris
Journal:  Am J Public Health       Date:  1996-08       Impact factor: 9.308

Review 3.  Systematic review with meta-analysis of the epidemiological evidence in the 1900s relating smoking to lung cancer.

Authors:  Peter N Lee; Barbara A Forey; Katharine J Coombs
Journal:  BMC Cancer       Date:  2012-09-03       Impact factor: 4.430

4.  Lung cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial.

Authors:  William G Hocking; Ping Hu; Martin M Oken; Stephen D Winslow; Paul A Kvale; Philip C Prorok; Lawrence R Ragard; John Commins; David A Lynch; Gerald L Andriole; Saundra S Buys; Mona N Fouad; Carl R Fuhrman; Claudine Isaacs; Lance A Yokochi; Thomas L Riley; Paul F Pinsky; John K Gohagan; Christine D Berg
Journal:  J Natl Cancer Inst       Date:  2010-05-04       Impact factor: 13.506

5.  Comprehensive assessment of the association between XPD rs13181 polymorphism and lung cancer risk.

Authors:  Hai-Ying Wu; Ling-Yu Ding
Journal:  Tumour Biol       Date:  2014-05-21

6.  Genetic association between ERCC5 rs17655 polymorphism and lung cancer risk: evidence based on a meta-analysis.

Authors:  Yujia Liang; Jun Deng; Ying Xiong; Songping Wang; Wei Xiong
Journal:  Tumour Biol       Date:  2014-03-05

7.  Contextual analysis and the success of translational research.

Authors:  Anthony Biglan; Michael E Levin
Journal:  Transl Behav Med       Date:  2016-03       Impact factor: 3.046

Review 8.  African-American smokers and cancers of the lung and of the upper respiratory and digestive tracts. Is menthol part of the puzzle?

Authors:  T L Richardson
Journal:  West J Med       Date:  1997-03

9.  Variation in smoking-related lung cancer risk factors by cell type among men in Argentina: a case-control study.

Authors:  S M Pezzotto; R Mahuad; M L Bay; J C Morini; L Poletto
Journal:  Cancer Causes Control       Date:  1993-05       Impact factor: 2.506

10.  Nucleotide excision repair genes and risk of lung cancer among San Francisco Bay Area Latinos and African Americans.

Authors:  Jeffrey S Chang; Margaret R Wrensch; Helen M Hansen; Jennette D Sison; Melinda C Aldrich; Charles P Quesenberry; Michael F Seldin; Karl T Kelsey; Rick A Kittles; Gabriel Silva; John K Wiencke
Journal:  Int J Cancer       Date:  2008-11-01       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.